Michael Bigham Net Worth & Insider Trades

Michael Bigham - Exec. Chairman the Board, Paratek Pharmaceuticals, Inc

As of September 21, 2023

What is Michael Bigham's Net Worth?

The current estimated net worth of Paratek Pharmaceuticals, Inc's Exec. Chairman the Board, Michael Bigham, is estimated to be about $4.33M . Michael Bigham owns about 1,334,702 units of Paratek Pharmaceuticals, Inc common stock. In the last 9 years at Paratek Pharmaceuticals, Inc, Michael Bigham has sold an estimated value of $2.31M worth.

What is Michael Bigham's Past Insider Trading?

Michael Bigham's largest purchase order was 20,000 units , worth over $269.01K on June 27, 2016. Michael Bigham's largest sale order was 34,364 units , worth over $333.33K on June 8, 2021. In total, Michael Bigham has made about 36 transactions over 9 years of their time at Paratek Pharmaceuticals, Inc. Michael Bigham usually trades in February, with the busiest year in 2018. The most recent transaction was a sale order of 31,250 units , worth over $68.75K on August 10, 2023.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Michael Bigham

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What was Michael Bigham's Salary in 2020?

As Exec. Chairman the Board of Paratek Pharmaceuticals, Inc, Michael Bigham has a total base salary of $500,000 . Michael Bigham received compensation valued at about $1,373,553 in 2020 after becoming Exec. Chairman the Board. The vast majority of their compensation came in the form of stock awards of $473,850 , other earnings, plans or compensations of $375,000 , and other compensation of $24,703 .

What is Michael Bigham's' Mailing Address?

  • Mailing address is 890 Winter Street Waltham MA 02451 MA

Paratek Pharmaceuticals, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Evan Loh, M.D. 2020 $575,000 - $505,440 $431,250 $22,921 $1,534,611
Evan Loh, M.D. 2019 $520,000 - $1,352,100 $364,375 $22,521 $2,258,996
Evan Loh, M.D. 2018 $480,000 - $1,011,725 $288,000 $21,434 $1,801,159
Michael F. Bigham 2020 $500,000 - $473,850 $375,000 $24,703 $1,373,553
Michael F. Bigham 2019 $515,000 - $1,352,100 $343,750 $22,928 $2,233,778
Michael F. Bigham 2018 $500,000 - $1,089,550 $330,000 $22,890 $1,942,440
Adam Woodrow 2020 $445,000 - $236,925 $250,313 $16,552 $948,790
Adam Woodrow 2019 $415,000 $48,375 $676,050 $193,500 $15,330 $1,348,225
Adam Woodrow 2018 $365,000 $35,040 $505,862 $140,160 $15,369 $1,061,431
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1178711/000120677421001229/prtk3887701-def14a.htm

What are Paratek Pharmaceuticals, Inc's Past Insider Trades?

Paratek Pharmaceuticals, Inc's most recent insider trade came on August 10, 2023 by Randall B Brenner who sold 27,603 units worth $60.73K . In the last 8 years, insiders at Paratek Pharmaceuticals, Inc have sold an estimated value of $9.41M and bought an estimated value of $14.19M worth of shares. Insider trading is most common in February, with the busiest year in 2018. The most active traders at the company are Evan Loh, CEO,  Michael Bigham, Exec. Chairman the Board,  and William M Haskel, CLO .

Paratek Pharmaceuticals, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...